Participants who took tirzepatide (Zepbound) dropped an average of 50 pounds over 72 weeks. Those who took semaglutide ...

Hims & Hers rebounds with key partnerships and launches, achieving 111% YoY revenue growth. Learn more about HIMS stock here.

The first head-to-head trial of two blockbuster weight-loss drugs has shown Mounjaro is more effective than rival Wegovy.

But new research suggests these drugs could be doing more than helping people shed pounds. Scientists at the University of ...

Weight-loss jab Mounjaro helps people shed much more weight than rival – study - Mounjaro (tirzepatide) and Wegovy ...